Skip to content

Scientific Evaluation of the CHECKPOINT-PLUS-Projects in Freiburg and Berlin

Scientific Evaluation of the CHECKPOINT-PLUS-Projects in Freiburg and Berlin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020957
Enrollment
3000
Registered
2021-04-29
Start date
2020-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A50-A64

Interventions

Group 1: Measuremnt of adherence to SOP concerning diagnosis and treatment of STIs
evaluation of number of visits and tests, composition of risk groups seeking advice
rate of re-tests after 3, 6 and 12 months

Sponsors

Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Individuals seeking STI counselling and testing

Exclusion criteria

Exclusion criteria: Age < 18 year, missing informed consent (ICF)

Design outcomes

Primary

MeasureTime frame
Adherence to SOPs on diagnosis and treatment of STIs, measured as proportion/in percentage after first clinic visit

Secondary

MeasureTime frame
Number of positive tests, number of (SOP-compliant) tests and consultations, time to (SOP-compliant) therapy initiation, number of requested PreP-consultations, number of recommended resp. performed vaccinations, rate of re-tests (retention in care), comparative analysis between hot spot/metropole region/urban setting and rural setting, number and comparison of tested people belonging to different risk groups (i.e. MSM, LGBTQI, sex workers, immigrants and refugees)

Countries

Germany

Contacts

Public ContactSiegbert Rieg

Abteilung Infektiologie, Klinik für Innere Medizin II, Universitätsklinikum Freiburg

siegbert.rieg@uniklinik-freiburg.de0761-27018190

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026